Sneddon's syndrome: 15 Cases with cerebral angiography;Le syndrome de Sneddon: Étude de 15 cas avec artériographie cérébrale

Revue Neurologique

Volumn 163, Issue 8-9, 2007, Pages 809-816

  Maamar, M ^a   Rahmani, M ^a   Aidi, S ^a   Benabdeljlil, M ^a   El Hassani My, R ^a   Jiddane, M ^a   Hicham, Ch ^b   El Alaoui Faris, M ^a  

^a IBN SINA HOSPITAL   (Morocco)

^b Cabinet de Neurologie   (Morocco)

Author keywords

Cerebral arteriopathy; Cerebro vascular ischemic events; Livedo reticularis; Vascular dementia

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; PHOSPHOLIPID ANTIBODY;

ADULT; ARTERY DISEASE; ARTERY THROMBOSIS; ARTICLE; BRAIN; BRAIN ANGIOGRAPHY; BRAIN INFARCTION; CLINICAL ARTICLE; DEMENTIA; DISEASE COURSE; DRUG WITHDRAWAL; FEMALE; HUMAN; INTERNAL CAROTID ARTERY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; RECURRENT DISEASE; RETROSPECTIVE STUDY; SNEDDON SYNDROME; WHITE MATTER;

EID: 34548689409     PISSN: 00353787     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0035-3787(07)91463-0     Document Type: Article

References (40)

1. ABOUZAHIR A, BOURAZZA A, RAFIQ R et al. (2003). Le syndrome de Sneddon : à propos de 6 cas. Rev Neurol. (Paris), 159: 1156-1162.
2. ALEGRE VA, WINKELMANN RK, GASTINEAU DA. (1990). Cutaneous thrombosis, cerebrovascular thrombosis and lupus anticoagulant. The Sneddon syndrome. Int J Dermatol. 29: 45-49.
3. ANTOINE JC, MICHEL D, GARNIER P, GENIN C. (1994). Rheumatic heart disease and Sneddon's syndrome. Stroke, 25: 689-691.
4. AQUINO-GONDIM F, LEACOCK RO, SUBRAMMANIAN TA, CRUZ-FLORES S. (2003). Intracerebral hemorrhage associated with Sneddon's syndrome: is ischemia-related angiomatosis the cause? Case report and review of literature. Neuroradiology, 45: 368-372.
5. BOLAYIR E, YILMAZ A, KUGU N, ERDOGAN H, AKYOL M, AKYUZ A. (2004). Sneddon's syndrome: Clinical and laboratory analysis of 10 cases. Acta Mad Okayama, 58: 59-65.
6. BRILEY DP, COULL BM, GOODNIGHT JR SH. (1989). Neurological disease associated with antiphospholipid antibodies. Ann Neurol, 25: 221-227.
7. BRUYN RPM. (1989). Sneddon's syndrome, in Toole JF (ed). Handbook of Clinical Neurology, vol 1. Vascular Diseases. Part III. Elsevier Science. 401-404.
8. CHAMPION RH, ROOK A. (1960). Levido reticularis. Proc R Soc Med, 53: 961-962.
9. FETONI V, GRISOLI M, SALMAGGI A, CARRIERO R, GIROTTI F. (2000). Clinical and neuroradiological aspects of Sneddon's syndrome and primary antiphospholipid antibody syndrome. A follow-up study. Neurol Sci, 21: 157-164.
10. FRANCES C, CACOUB P, PIETTE JC. (2000). Autres vascularites et pseudo-vascularites. In Maladies et syndromes systémiques KAHN MF, PELTIER AP, MEYER O, PIETTE JC. Ed Flammarion, Paris, 28: 855-858.
11. FRANCES C, PAPO T, WECHSLER B, LAPORTE JL, BIOUSSE V, PIETTE JC. (1999). Sneddon's syndrome with or without antiphospholipid antibodies: a comparative study in 46 patients. Medicine (Baltimore), 78: 209-219.
12. FRANCES C, PIETTE JC. (2000). The mistery of Sneddon's syndrome: Relationship with antiphospholipid syndrome and systemic lupus erythematosus. J. Auto-imm, 15: 139-143.
13. GOBERT A. (1995). Sneddon's syndrome with bilateral peripheral retinal neovascularization. Bull Soc Belge Ophtalmol, 255: 85-90.
14. HACHULLA E, BATAILLE D, JAMIN A et al. (1992). Double remplacement valvulaire révélateur d'un syndrome des antiphospholipides. Rev. Med. Interne, 13: 221-224.
15. HACHULLA E, PIETTE AM, HATRON PY, BLETRY O. (2000). Aspirine et syndrome des antiphopholipides. Rev. Med. Interne, 21 Suppl: 83-88.
16. KALASHNIKOVA LA, NASONOV EL, BORISENKO VV, USMAN VB, PRUDNIKOVA LZ, KOVALJOV VU, KUSHEKBAEVA AF. (1991). Sneddon's syndrome: cardiac pathology and antiphospholipid antibodies. Clin. Exp. Rheumatol., 9: 357-361.
17. KALASHNIKOVA LA, NASONOV EL, STOYANOVICH LZ, KOVALEV VU, KOSHELEVA NM, RESHETNYAK TM. (1994). Sneddon's syndrome and the primary antiphospholipid syndrome. Cerebrovasc. Dis, 4: 76-82.
18. KAMASHTA MA, CUADRADO MJ, MUJIK F, TAUB NA, HUNT BJ, HUGUES GR. (1995). The management of thrombosis in the phospholipid-antibody syndrome. N. Engl. J. Med, 332: 993-997.
19. KAWAGUSHI S, SAKAKI T, KAKIZAKI T, KAMADA K, SHIMOMURA T, IWANAGA H. (1996). Clinical features of the hemorrhage type moyamoya disease based on 31 cases. Acta Neurochir, 138: 1200-1210.
20. KUME M, IMAI H, MOTEGI M, MIURA S, NAMURA I. (1996). Sneddon's syndrome (Livedo racemosa and cerebral infarction) Presenting Psychiatric Disturbance and Shortening of Fingers and Toes. Internal Medicine, 35: 668-673.
21. LOUSA M, SASTRE JL, CANCELAS JA, GOBERNADO JM, PARDO A. (1994). Study of antiphospholipid antibodies in a patient with Sneddon's syndrome and her family. Stroke, 25: 1071-1074.
22. LUBACH D, STAMM T. (1982). Cerebral infarction and livedo racemosa generalised (Ehrmann). Fortschr Med, 100: 676-680.
23. MUEZZA FM, GONZALES G, ORTIZ E, SARAUBAR N. (1998). Hemorragia cerebral en el sindrome Sneddon. Neurologia, 27: 74-76.
24. PIETTE JC, AMOURA Z, WECHSLER B, FRANCES C. (1998). Manifestations neurologiques du syndrome des antiphospholipides. Rev Med Interne, 19 (Suppl): 39-45.
25. PUISIEUX F, DE GROOTE P, MILLIAIRE A, HATRON PY, DUCLOUX G. (1996). Syndrome de Sneddon et valvulopathie mitrale. Ann Cardiol Angeiol, 45: 64-67.
26. RAUTENBERG W, HENNERICI M, AULICH A, HOLZLE E, LAKOMEK HJ. (1988). Immunosuppressive therapy and Sneddon's syndrome. Lancet, 2: 629-630.
27. REBOLLO M, VAL JF, GARIJO F, QUINTANA F, BERCIANO J. (1983). Livedo reticularis and cerebrovascular lesions (Sneddon's syndrome). Clinical, radiological and pathological features in 8 cases. Brain, 106: 965-979.
28. REHANY U, KASSIF Y, RUMELT S. (1998). Sneddon's syndrome: Neuro-ophtalmologic manifestation in a possible autosomal recessive pattern. Neurology, 51: 1185-1187.
29. RUMPLE, NEUHOFER J, PALLUA A et al. (1985). Cerebrovascular lesions and livedo reticularis (Sneddon's syndrome). A progressive cerebrovascular disorder ? J Neurol, 231: 324-330.
30. RUSCALLEDA J, COSCOJUELA P, GUARDIA E et al. (1991). Sneddon's syndrome. Radiographics, 11: 929-931.
31. SCHELLONG SM, WEISSENBORN K, NIEDERMEYER J, WOLLENHAUPT J, SOSADA M, EHRENHEIM C, LUBACH D. (1997). Classification of Sneddon's syndrome. VASA, 26: 215-221.
32. SERRANO-POZO A, GOMEZ-ARANDA F, FRANCO-MACIAS E, SERRANO-CABRERA A. (2004). Cerebral haemorrhage in Sneddon's syndrome: case report and literature review. Rev Neurol, 39: 731-733.
33. SNEDDON IB. (1965). Cerebrovascular lesions and livedo reticularis. Br J Dermatol, 77: 180-185.
34. STOCKHAMMER G, STEPHAN R, FELBER R, ZELGER B, SEPP N, BIRBAMER G, FRITSCH P, AICHNER F. (1993). Sneddon's syndrome. Diagnostic by skin biopsy and RMI in 17 patients. Stroke, 24: 685-690.
35. STONE J, BHATTACHARYA J WALLS TJ. (2001). Divry-Van Bogaert syndrome in females: relationship to Sneddon's syndrome and radiographic appearances. Neuroradiology, 43: 562-564.
36. THOMAS P, LEBRUN C, MAHAGNE MH, DESMUELLES C, CHATEL M. (1993). Encéphalopathie ischémique au cours du syndrome primaire des anticorps antiphospholipides. Rev Neurol (Paris), 149: 336-339.
37. TOURBAH A, PIETTE JC, BENOIT N, IBA-ZIZEN MT, LYON-CAEN O, FRANCES C. (1997). Aspects cliniques, biologiques et neuroradiologiques du syndrome de Sneddon: 26 observations. Rev Neurol (Paris), 153: 652-658.
38. UIDEHAAG BMJ, SCHELTENS P, BERTELSMANN FW, BRUYN RPM. (1992). Intracerebral haemmorrage in Sneddon's syndrome. J Neurol Sci., 111: 227-228.
39. WEISSENBORN K, LUBACH D, SCHWABE C, BECKER H. (1989). Sneddon's syndrome: clinical course and outcome. J Neurol, 236: 34-37.
40. ZELGER B, SEPP N, STOCKHAMMER G, DOSCH E, HILTY E, OFNER D, AICHNER F, FRITSCH O. (1993). Sneddon's syndrome. A long term follow up of 21 patients. Arch Dermatol, 129: 437-447.